Tattva, founder of Art of Living, Sri Sri Ravi Shankar, said on Monday that he had found a way to prevent and treat the coronavirus, IANS reported. However, the company has promoted the drugs – a combination of Ayurvedic and siddha drugs – as “immunity boosting” formulations.
In a virtual press conference on Monday, Shankar said doses of the product had been donated to the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy, or AYUSH, for the treatment. and prevention of Covid-19. “We have seen that hospital beds are also coming to an end,” he said. “We must not create a division between old and modern treatment systems. It’s time to take a holistic approach.
The company said it has tested the formulations under the direction of the Frankfurt Innovation Center for Biotechnology based in Germany. He added that the formulations were also being distributed in Tamil Nadu.
Ravi Reddy, Scientific Director of Tattva, said The imprint that “the results relate to in vitro studies using the following Sri Sri Tattva products: Kabasura Kudineer, Amruth, Immugen and Chyawanprash”.
“The study found that Kabasura Kudineer tablets were the most potent advanced glycoprotein inhibitor in coronavirus strains, limiting entry of the virus into cells in in vitro studies,” the company said in his press release. The spike glycoprotein is the part of the virus that allows it to attach to the human cell. In vitro studies are those carried out in clinical laboratories.
The chief executive of the Frankfurt Innovation Center for Biotechnology, Christian Garbe, said the company launched the “ayurgenomics research” project in mid-2020. “Ayurgomics means using genomic tools for Ayurveda and studying the correlation between Prakriti (individual psycho-physiological makeup) and genomics,” he said.
Ramdev’s Patanjali Ayurved claimed in June that he had made two drugs that have shown 100% effectiveness in patients with coronavirus. The Union Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy, or AYUSH, had banned Patanjali from promoting these products. However, on July 1, the ministry said the company could sell the products, but only as a medicine for the “management” of the coronavirus, not for its treatment. We do not know what “management” means.
India has more than 94 lakh cases of coronavirus and more than 1,37,621 deaths, according to the latest data from the Union’s Ministry of Health and Family Welfare.